8 results on '"Valentina Pensato"'
Search Results
2. Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
- Author
-
Valentina Salvestrini, Marilena Ciciarello, Valentina Pensato, Giorgia Simonetti, Maria Antonella Laginestra, Samantha Bruno, Martina Pazzaglia, Elena De Marchi, Dorian Forte, Stefania Orecchioni, Giovanni Martinelli, Francesco Bertolini, Simon Méndez-Ferrer, Elena Adinolfi, Francesco Di Virgilio, Michele Cavo, and Antonio Curti
- Subjects
acute myeloid leukemia ,bitter taste receptors ,denatonium benzoate ,bone marrow microenvironment ,bitter compounds ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
The contribution of cell-extrinsic factors in Acute Myeloid Leukemia (AML) generation and persistence has gained interest. Bitter taste receptors (TAS2Rs) are G protein-coupled receptors known for their primary role as a central warning signal to induce aversion toward noxious or harmful substances. Nevertheless, the increasing amount of evidence about their extra-oral localization has suggested a wider function in sensing microenvironment, also in cancer settings. In this study, we found that AML cells express functional TAS2Rs. We also highlighted a significant association between the modulation of some TAS2Rs and the poor-prognosis AML groups, i.e., TP53- and TET2-mutated, supporting a potential role of TAS2Rs in AML cell biology. Gene expression profile analysis showed that TAS2R activation with the prototypical agonist, denatonium benzoate, significantly modulated a number of genes involved in relevant AML cellular processes. Functional assay substantiated molecular data and indicated that denatonium reduced AML cell proliferation by inducing cell cycle arrest in G0/G1 phase or induced apoptosis via caspase cascade activation. Moreover, denatonium exposure impaired AML cell motility and migratory capacity, and inhibited cellular respiration by decreasing glucose uptake and oxidative phosphorylation. In conclusion, our results in AML cells expand the observation of cancer TAS2R expression to the setting of hematological neoplasms and shed light on a role of TAS2Rs in the extrinsic regulation of leukemia cell functions.
- Published
- 2020
- Full Text
- View/download PDF
3. The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor
- Author
-
Valentina Pettirossi, Alessandra Venanzi, Ariele Spanhol-Rosseto, Gianluca Schiavoni, Alessia Santi, Luisa Tasselli, Marta Naccari, Valentina Pensato, Alessandra Pucciarini, Maria Paola Martelli, Hans Drexler, Brunangelo Falini, and Enrico Tiacci
- Subjects
Cancer Research ,Oncology ,Hematology - Published
- 2023
4. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing—a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking
- Author
-
Daryl L. Davies, Kamila Bujko, Janina Ratajczak, Valentina Pensato, Mateusz Adamiak, Arjun Thapa, Mariusz Z. Ratajczak, Henning Ulrich, Katarzyna Brzezniakiewicz-Janus, Magda Kucia, Adamiak M., Bujko K., Thapa A., Pensato V., Brzezniakiewicz-Janus K., Ratajczak J., Davies D.L., Ulrich H., Kucia M., and Ratajczak M.Z.
- Subjects
Cancer Research ,medicine.drug_class ,Haematopoietic stem cells, Medical research ,Biology ,Mice ,Granulocyte Colony-Stimulating Factor ,medicine ,Animals ,Humans ,Stem Cell Niche ,Progenitor cell ,Receptor ,Mice, Knockout ,Chemotaxis ,Purinergic receptor ,Hematopoietic Stem Cell Transplantation ,ADENOSINA ,Hematology ,Purinergic signalling ,Hematopoietic Stem Cells ,Receptor antagonist ,Hematopoietic Stem Cell Mobilization ,Cell biology ,Mice, Inbred C57BL ,Transplantation ,Oncology ,Female ,Receptors, Purinergic P2X7 ,Stem cell ,Receptors, Purinergic P2X4 ,Signal Transduction ,Homing (hematopoietic) - Abstract
Recent evidence indicates that extracellular adenosine triphosphate (eATP), as a major mediator of purinergic signaling, plays an important role in regulating the mobilization and homing of hematopoietic stem progenitor cells (HSPCs). In our previous work we demonstrated that eATP activates the P2X7 ion channel receptor in HSPCs and that its deficiency impairs stem cell trafficking. To learn more about the role of the P2X purinergic receptor family in hematopoiesis, we phenotyped murine and human HSPCs with respect to the seven P2X receptors and observed that, these cells also highly express P2X4 receptors, which shows ~50% sequence similarity to P2X7 subtypes, but that P2X4 cells are more sensitive to eATP and signal much more rapidly. Using the selective P2X4 receptor antagonist PSB12054 as well as P2X4-KO mice, we found that the P2X4 receptor, similar to P2X7 receptor, promotes trafficking of HSPCs in that its deficiency leads to impaired chemotaxis of HSPCs in response to a stromal-derived factor 1 (SDF-1) gradient, less effective pharmacological mobilization, and defective homing and engraftment of HSPCs after transplantation into myeloablated hosts. This correlated with a decrease in SDF-1 expression in the BM microenvironment. Overall, our results confirm the proposed cooperative dependence of both receptors in response to eATP signaling. In G-CSF-induced mobilization, a lack of one receptor is not compensated by the presence of the other one, which supports their mutual dependence in regulating HSPC trafficking.
- Published
- 2021
5. Innate immunity orchestrates the mobilization and homing of hematopoietic stem/progenitor cells by engaging purinergic signaling—an update
- Author
-
Arjun Thapa, Mariusz Z. Ratajczak, Kamila Bujko, Magda Kucia, Henning Ulrich, Mateusz Adamiak, Valentina Pensato, Janina Ratajczak, Ratajczak M.Z., Adamiak M., Bujko K., Thapa A., Pensato V., Kucia M., Ratajczak J., and Ulrich H.
- Subjects
0301 basic medicine ,Adenosine ,Review Article ,Biology ,Hematopoietic stem cell ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Bone Marrow ,Cell Movement ,medicine ,Animals ,Humans ,Extracellular ATP ,Progenitor cell ,Molecular Biology ,Innate immunity ,Innate immune system ,Purinergic signaling ,ADENOSINA ,Cell Biology ,Stem cell mobilization and homing ,Purinergic signalling ,Hematopoietic Stem Cells ,Hematopoietic Stem Cell Mobilization ,Immunity, Innate ,Cell biology ,Transplantation ,Haematopoiesis ,030104 developmental biology ,medicine.anatomical_structure ,Bone marrow ,030217 neurology & neurosurgery ,Homeostasis ,Homing (hematopoietic) - Abstract
Bone marrow (BM) as an active hematopoietic organ is highly sensitive to changes in body microenvironments and responds to external physical stimuli from the surrounding environment. In particular, BM tissue responds to several cues related to infections, strenuous exercise, tissue/organ damage, circadian rhythms, and physical challenges such as irradiation. These multiple stimuli affect BM cells to a large degree through a coordinated response of the innate immunity network as an important guardian for maintaining homeostasis of the body. In this review, we will foc++us on the role of purinergic signaling and innate immunity in the trafficking of hematopoietic stem/progenitor cells (HSPCs) during their egression from the BM into peripheral blood (PB), as seen along pharmacological mobilization, and in the process of homing and subsequent engraftment into BM after hematopoietic transplantation. Innate immunity mediates these processes by engaging, in addition to certain peptide-based factors, other important non-peptide mediators, including bioactive phosphosphingolipids and extracellular nucleotides, as the main topic of this review. Elucidation of these mechanisms will allow development of more efficient stem cell mobilization protocols to harvest the required number of HSPCs for transplantation and to accelerate hematopoietic reconstitution in transplanted patients.
- Published
- 2020
6. A Novel Underappreciated Role for the Extracellular Adenosine Triphosphate (ATP)-P2X4 Purinergic Receptor Axis in the Homing and Engraftment of HSPCs
- Author
-
Mateusz Adamiak, Janina Ratajczak, Mariusz Z. Ratajczak, Arjun Thapa, Magdalena Kucia, Valentina Pensato, and Kamila Bujko
- Subjects
chemistry.chemical_compound ,chemistry ,Immunology ,Purinergic receptor ,Extracellular ,Cell Biology ,Hematology ,Biochemistry ,Adenosine triphosphate ,Cell biology ,Homing (hematopoietic) - Abstract
Background. Adenosine triphosphate (ATP) is an important nucleotide involved in intracellular energy transfer, but when released from activated cells into the extracellular space as extracellular ATP (eATP) it becomes a crucial mediator of the purinergic signaling network. Purinergic receptors for extracellular nucleotides (EXNs), expressed on the surface of all cells in the body, are represented by the P1, P2X, and P2Y receptor families, which are among the most abundant receptors in living organisms. Of all these receptors, the P2X receptor family is most highly specific for eATP signaling and consists of seven members (P2X1-7). We found that human and murine hematopoietic stem progenitor cells (HSPCs) highly express two members of this family, the P2X4 and P2X7 receptors. We recently reported that both are involved in optimal mobilization of HSPCs by activating Nlrp3 inflammasome (Leukemia 2020 Jun;34(6):1512-1523 and Stem Cell Rev Rep. 2019 Jun;15(3):391-403). We also reported that the P2X7 receptor expressed on the surface of HSPCs facilitates the homing and engraftment of HSPCs by increasing their responsiveness to SDF-1 gradients. Interestingly, it has been proposed that both receptors heterodimerize to exert optimal activity. Hypothesis. Since, the P2X4 and P2X7 receptors show several similar biological effects in non-hematopoietic cells, we became interested in the role of the P2X4 receptor in homing and engraftment of HSPCs.Materials and Methods. To test this hypothesis, we isolated SKL cells from P2X4-KO mice and tested them for migration in response to BM chemoattractants, including the major homing factor SDF-1. Next, we tested the short- and long-term homing of mouse BM cells after exposure to the P2X4-specific inhibitor PBS12054 in normal mice by evaluating the number of donor-derived PKH67-labeled BMMNCs and CFU-GM clonogenic progenitors isolated from recipient mouse BM 24 hours after transplantation as well as the number of day-12 colony-forming units in spleen (CFU-S) and day-12 CFU-GM clonogenic progenitors. These data were confirmed in transplant studies employing P2X4-KO bone marrow cells. In parallel, we also evaluated the recovery kinetics of leukocytes and blood platelets in the PB of transplanted animals. Finally, we also perturbed P2X4 expression in transplanted mice with PBS12054 and studied the effect on homing and engraftment of normal BM cells, as described above. Results. We found that P2X4-KO mouse HSPCs have a defect in migration in response to BM chemoattractants involved in BM homing, including the major homing factor SDF-1 as well as the supportive factors S1P and eATP. Perturbation of P2X4 expression on the surface of HSPCs led to significant defective homing and engraftment of HSPCs. Moreover, inhibition of P2X4 in the recipient mouse BM microenvironment had a similar effect. Conclusions. We identified for the first time the role of eATP-P2X4 signaling in the homing and engraftment of HSPCs. To explain this result, we conclude that the eATP-P2X4 axis is, like the eATP-P2X7 axis, a potent activator of Nlrp3 inflammasomes and that defective eATP-P2X4 signaling impairs the role of purinergic signaling and the Nlrp3 inflammasome in homing and engraftment. Moreover, our results show a similar homing and engraftment phenotype for P2X4-KO mice as that seen in P2X7-KO animals, which provides functional support for the proposed dimerization of P2X7 with P2X4 receptors and the necessary presence of both receptors for optimal function. This question is currently being addressed in our laboratory by employing the fluorescence resonance energy transfer (FRET) technique. Finally, we provide additional evidence that, in addition to SDF-1 and S1P, eATP and purinergic signaling involving P2X4 and P2X7 receptors is an important and underappreciated regulator of HSPC trafficking and a potential target for molecular optimization of both processes. Disclosures No relevant conflicts of interest to declare.
- Published
- 2020
7. Abstract 4946: Bitter taste receptors system is expressed and functional in both HSCs and leukemic cells
- Author
-
Valentina Salvestrini, Stefania Orecchioni, Samantha Bruno, Francesco Bertolini, Michele Cavo, Giovanni Martinelli, Antonio Curti, Valentina Pensato, Elena Adinolfi, Martina Pazzaglia, Simón Méndez-Ferrer, Giorgia Simonetti, Marilena Ciciarello, Elena De Marchi, and Dorian Forte
- Subjects
Cancer Research ,education.field_of_study ,Cell ,Population ,Biology ,medicine.disease ,Haematopoiesis ,Leukemia ,medicine.anatomical_structure ,Oncology ,Cancer cell ,medicine ,Cancer research ,Stem cell ,education ,Clonogenic assay ,Receptor - Abstract
Acute Myeloid Leukemia (AML) is a clonal disease developing from a rare population of leukemic stem cells. Alongside the identification of disease-specific alleles harbored by AML clones, the contribution that cell-extrinsic factors have in AML generation and persistence by influencing AML cell genomic landscape and therapy-resistance is gaining increasing interest. In the cross-talk between AML cells and their microenvironment, several membrane receptors sense the external changes by triggering intracellular signals. Among these, the largest group belongs to the family of G protein-couple receptors (GPCRs). Bitter taste receptors (T2Rs) comprise 25 distinct members of the GPCR family. Initially described in the oral cavity, T2Rs are actually widely expressed in different tissues and in various cancer cell types. In the present work, we showed that AML cells expressed fully functional T2R subtypes. Their activation substantially modified the AML cell transcriptomic profile and deregulated relevant cellular processes, resulting in inhibited clonogenic capacity, proliferation and cell motility and induced apoptosis. In addition, T2R stimulation with agonist altered mitochondrial bioenergetic capacity and made AML cells more prone to oxidative and metabolic stress. Given the effect of T2R activation on crucial AML cell function, we tested the therapeutical potential of targeting T2Rs. Interestingly, we observed that T2R stimulation had a synergistic effect with cytarabine, reducing leukemia cell viability and allowing to reach high toxicity using lower doses of chemotherapic agent. Then we analyzed T2Rs expression and function on normal hematopoietic stem cells (HSCs). HSCs expressed several T2R subtypes with some differences compare to AML cells. T2Rs activation didn't affect HSCs viability and motility, conversely to AML cells, but significantly inhibited clonogenic capacity, by reducing the frequency of precursors. Our data may suggest a role for microenvironment “bitter” molecules in regulating normal and leukemic hematopoiesis. Notably, many common drugs, such as antibiotics, chloroquine, haloperidol, procainamide, are bitter tasting and are thus effective ligands for T2Rs. For this reason, they could exhibit an off-target effect in T2R expressing cells, including leukemic and normal hematopoietic cells. Our results may have implications in understanding the off-target actions of diverse drugs and could reveal potential new therapeutic targets Citation Format: Valentina Salvestrini, Valentina Pensato, Marilena Ciciarello, Giorgia Simonetti, Samantha Bruno, Martina Pazzaglia, Elena De Marchi, Dorian Forte, Stefania Orecchioni, Giovanni Martinelli, Francesco Bertolini, Simon Mendez-Ferrer, Elena Adinolfi, Michele Cavo, Antonio Curti. Bitter taste receptors system is expressed and functional in both HSCs and leukemic cells [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 4946.
- Published
- 2020
8. Bitter Taste Receptors System Is Expressed and Functional in Both HSCs and Leukemic Cells
- Author
-
Antonio Curti, Giovanni Martinelli, Valentina Salvestrini, Valentina Pensato, Simón Méndez-Ferrer, Marilena Ciciarello, Dorian Forte, Michele Cavo, and Giorgia Simonetti
- Subjects
Gastrointestinal tract ,Immunology ,Cell Biology ,Hematology ,Mitochondrion ,Biology ,medicine.disease ,Biochemistry ,Cell biology ,Gene expression profiling ,Leukemia ,Cell culture ,medicine ,Cytarabine ,Endocrine system ,G protein-coupled receptor ,medicine.drug - Abstract
Acute Myeloid Leukemia (AML) is a clonal disease sprouting from a rare population of leukemic stem cells. Over the past years, increasing interest is gaining the contribution that cell-extrinsic factors have in AML generation and maintenance. In this context, the ability of leukemia cells to detect changes in the microenvironment is important in responsiveness to environmental fluctuations. Bitter taste receptors (T2Rs) are typical G-protein coupled receptors and are normally found on the surface of the tongue. Recent studies showed that T2Rs are widely expressed in various parts of human anatomy and have been shown to be involved in physiology of respiratory system, gastrointestinal tract and endocrine system. thus suggesting a wider function in "sensing microenvironment". We recently reported that AML cell lines OCI-AML3, THP-1, and AML primary cells expressed fully functional T2Rs subtypes. Gene expression profile analysis showed that after T2Rs activation, leukemic cell lines underwent down-regulation of genes involved in positive regulation of cell proliferation, migration, and cell-cycle. Whereas genes involved in cell adhesion and DNA repair were up-regulated. Functional assays supported these results (Blood 2017 130:3949). In the present work, we further investigated the role of T2Rs in BM microenvironment by extending the analysis to AML primary samples and to normal hematopoietic stem cells (HSCs). Similarly to AML cell lines, T2Rs activation with high dose of agonist induced a reduction of cell viability associated to apoptosis induction, while non-toxic doses reduced cell migration and clonogenic capacity. In addition, T2Rs stimulation with agonist makes AML cell lines more prone to oxidative and metabolic stress. Leukemia cells displayed a quiescent phenotype in response to T2Rs activation suggesting that mitochondrial activity is significantly limited by T2Rs agonist treatment. Since no data are available on the presence and the function of T2Rs on normal hematopoietic stem cell counterpart, we characterized T2Rs expression on CD34+ cell isolated from healthy donor. CD34+ cells express several T2Rs subtype without significant differences compare to AML cells. Their activation with high dose of agonist reduced HSCs viability inducing apoptosis, while non-cytotoxic doses reduced clonogenic capacity and promoted migration. Given the effect of T2Rs activation on crucial AML cell function, we tested the therapeutical potential of T2R agonist with and without conventional chemioterapic agent. Interestingly we observed that T2Rs agonist have a synergistic effect with cytarabine, reducing leukemia cell viability when combined with ARA-C compared to their use as single compound. The combination allowed to reach a high toxicity using lower doses of chemotherapic agent. Overall our results indicate that T2Rs receptor system is expressed and functional in both leukemic cells and HSCs. In particular, in AML cells T2Rs activation is associated with quiescence induction and prevention of migration. T2Rs stimulation modulates HSCs function but their role need to be further deepen. These data may suggest a role for microenvironment "bitter" molecules in regulating normal and leukemic hematopoiesis. Disclosures Cavo: AbbVie: Honoraria, Membership on an entity's Board of Directors or advisory committees; GlaxoSmithKline: Honoraria, Membership on an entity's Board of Directors or advisory committees; Bristol-Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees; Adaptive Biotechnologies: Honoraria, Membership on an entity's Board of Directors or advisory committees; Takeda: Honoraria, Membership on an entity's Board of Directors or advisory committees; Janssen: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Amgen: Honoraria, Membership on an entity's Board of Directors or advisory committees.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.